State NJ
Clinical Trials in New Jersey
New Jersey is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Jersey and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 247 actively recruiting studies with New Jersey sites out of 247 registered in total. The busiest research areas in New Jersey are Breast Cancer, Multiple Myeloma, Endometrial Cancer. Leading sponsors running trials in the state include Memorial Sloan Kettering Cancer Center, Rutgers, The State University of New Jersey, AstraZeneca. By stage, New Jersey trials break down as Phase 1 (46), Phase 2 (74), Phase 3 (77), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 247 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 247. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT05925101 N/A
Recruiting
Basic and Applied Research on Extinction Bursts
Condition
Problem Behavior
Enrollment
40 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06469281 Phase 1
Recruiting
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Ther...
Condition
Epithelial Ovarian Cancer
Enrollment
90 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
NCT07399977 N/A
Recruiting
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboemboli...
Condition
Venous Thromboembolism
Enrollment
259 pts
Location
United States, Australia
Sponsor
Memorial Sloan Kettering Cance
NCT06738615 N/A
Recruiting
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity
Condition
Mitral Insufficiency
Enrollment
40 pts
Location
United States
Sponsor
Atlantic Health System
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
NCT06095089 Phase 1
Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Condition
Prostatic Neoplasms
Enrollment
355 pts
Location
United States, Australia, China
Sponsor
Janssen Research & Development
NCT07507643 Phase 3
Recruiting
A Study of Methylprednisolone in People Having Liver Surgery
Condition
Hepatectomy
Enrollment
750 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07705035 Phase 1
Recruiting
DBC-664 in Adult Patients With Solid Tumors
Condition
Malignant Germ Cell Tumor
Enrollment
210 pts
Location
United States
Sponsor
Duboce Biopharmaceuticals, Inc
NCT07812753 N/A
Recruiting
Modulating Neural Mechanisms of Reward Processing in Tobacco Users
Condition
Tobacco Use Disorder
Enrollment
54 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07446439 Phase 3
Recruiting
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1...
Condition
Nausea and Vomiting
Enrollment
280 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06880302 N/A
Recruiting
Male Infertility and Assisted Reproductive Technologies Research Biobank
Condition
Male Infertility
Enrollment
1,000 pts
Location
United States
Sponsor
Reproductive Medicine Associat
NCT04291612 N/A
Recruiting
Observational Study of Women With Endometrial Cancer Who Receive the Standard Tr...
Condition
Endometrial Cancer
Enrollment
1,715 pts
Location
United States, Czechia, Italy
Sponsor
Memorial Sloan Kettering Cance
NCT06477172 N/A
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Condition
Post Procedural Erythema
Enrollment
500 pts
Location
United States, Canada
Sponsor
Acorn Biolabs Inc.
NCT03802695 Phase 1
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation fo...
Condition
Acute Myeloid Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Orca Biosystems, Inc.
NCT06954337 N/A
Recruiting
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-U...
Condition
Breast Cancer
Enrollment
1,750 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07414836 Phase 1
Recruiting
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
84 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
NCT05471856 Phase 1
Recruiting
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlima...
Condition
Solid Tumors
Enrollment
66 pts
Location
United States, Japan, Spain
Sponsor
Boehringer Ingelheim
NCT06642181 Phase 1
Recruiting
Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Ma...
Condition
Mindfulness
Enrollment
224 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05313165 N/A
Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-St...
Condition
Critical Limb Ischemia
Enrollment
100 pts
Location
United States
Sponsor
LimFlow, Inc.
NCT07271667 Phase 2
Recruiting
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in ...
Condition
Chronic Lymphocytic Leukemia
Enrollment
108 pts
Location
United States, Italy, Spain
Sponsor
Curis, Inc.
NCT05509777 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Diseas...
Condition
Crohn's Disease
Enrollment
90 pts
Location
United States, Austria, Belgium
Sponsor
Eli Lilly and Company
NCT06699602 Phase 2
Recruiting
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcino...
Condition
Renal Cell Carcinoma
Enrollment
10 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology